Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015Alan S. Coates, Andrew Tutt, Binghe Xu et al.|Annals of Oncology|2015Cited by 1.8k
Burdens and Benefits of Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil and Tamoxifen for Elderly Patients With Breast Cancer: The International Breast Cancer Study Group Trial VIIDiana Crivellari, Marco Bonetti, Monica Castiglione‐Gertsch et al.|Journal of Clinical Oncology|2000Cited by 295
Identifying Breast Cancer Patients at High Risk for Bone MetastasesMarco Colleoni, Anne O’Neill, Aron Goldhirsch et al.|Journal of Clinical Oncology|2000Cited by 125
Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: Long-term follow up on IBCSG Trial IXStefan Aebi, Aron Goldhirsch, Zijie Sun et al.|Annals of Oncology|2011Cited by 55